Skip to main content
. 2015 Feb 23;41(7):636–648. doi: 10.1111/apt.13121

Table 2.

Dose–response relationship for mean 24-h intragastric pH >4 and >5 holding time ratio [HTR (%)] during the 24-h dosing interval and during the night-time period in healthy male subjects who received TAK-438 10–40 mg once daily at a fixed dose level for 7 consecutive days in Japanese and UK studies (Pharmacodynamic analysis set: Japan N = 60; UK N = 48)

TAK-438
Placebo 10 mg 15 mg 20 mg 30 mg 40 mg
Japanese study
n 15 9 9 9 9 9
24-h pH >4 HTR (%)
 Day 1 8.3 ± 4.0 38.4 ± 22.3 55.4 ± 13.2 63.3 ± 17.9 80.8 ± 14.0 85.3 ± 8.3
 Day 7 5.6 ± 3.5 63.3 ± 8.7 68.5 ± 16.1 83.4 ± 16.7 95.2 ± 10.1 100.0 ± 0.0
24-h pH >5 HTR (%)
 Day 1 3.7 ± 2.4 25.1 ± 19.0 40.3 ± 16.8 53.5 ± 21.5 73.1 ± 16.1 78.3 ± 10.6
 Day 7 1.5 ± 1.5 52.6 ± 10.7 60.2 ± 16.8 73.2 ± 18.9 92.0 ± 12.5 98.6 ± 2.0
Night-time pH >4 HTR (12–24 h post-dose) (%)
 Day 1 3.0 ± 3.8 32.4 ± 18.7 50.5 ± 18.6 61.1 ± 29.3 78.1 ± 24.8 86.5 ± 15.5
 Day 7 2.0 ± 2.4 39.0 ± 13.1 48.8 ± 22.2 73.0 ± 26.5 90.4 ± 20.1 100 ± 0.1
Night-time pH >5 HTR (12–24 h post-dose) (%)
 Day 1 1.0 ± 1.6 18.6 ± 14.3 30.4 ± 19.2 47.9 ± 31.8 64.5 ± 29.3 73.6 ± 19.6
 Day 7 0.3 ± 0.6 27.1 ± 12.9 37.2 ± 19.4 55.9 ± 27.5 84.5 ± 24.2 97.2 ± 4.0
UK study
n 12 9 9 9 9
24-h pH >4 HTR (%)
 Day 1 6.2 ± 3.2 43.1 ± 21.2 62.7 ± 16.8 76.8 ± 9.9 85.6 ± 7.4
 Day 4 10.5 ± 10.6 58.9 ± 20.9 82.9 ± 14.7 90.2 ± 9.2 94.0 ± 9.1
 Day 7 6.5 ± 4.5 60.2 ± 19.1 85.2 ± 12.3 90.1 ± 7.9 93.2 ± 10.5
24-h pH >5 HTR (%)
 Day 1 2.6 ± 2.0 31.5 ± 20.8 49.2 ± 19.9 64.8 ± 15.4 73.1 ± 11.0
 Day 4 6.7 ± 10.6 43.4 ± 18.5 75.3 ± 19.3 81.5 ± 11.6 88.6 ± 11.9
 Day 7 3.2 ± 3.2 49.5 ± 15.8 78.6 ± 14.0 79.9 ± 13.7 85.0 ± 21.7
Night-time pH >4 HTR (20:00–08:00 hours) (%)
 Day 1 2.1 ± 2.1 36.3 ± 21.2 57.3 ± 23.2 74.4 ± 17.3 87.7 ± 11.4
 Day 4 2.8 ± 3.9 37.5 ± 19.2 73.8 ± 22.4 81.2 ± 18.2 91.0 ± 14.5
 Day 7 4.8 ± 5.3 36.9 ± 16.4 75.4 ± 20.6 81.3 ± 15.2 90.4 ± 14.8
Night-time pH >5 HTR (20:00–08:00 hours) (%)
 Day 1 1.1 ± 1.3 24.2 ± 20.8 37.8 ± 27.4 55.2 ± 24.5 65.6 ± 18.3
 Day 4 1.0 ± 2.0 17.9 ± 10.8 61.6 ± 29.3 68.4 ± 21.2 84.1 ± 18.2
 Day 7 2.2 ± 3.4 22.8 ± 10.9 66.9 ± 22.2 65.9 ± 26.5 77.5 ± 32.5

All data are represented as mean ± s.d. HTR, holding time ratio; s.d., standard deviation.

HHS Vulnerability Disclosure